We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
DELISTED
Neurotrope, Inc. Common
NTRP
| $65K | ﹤0.01% |
+12,527
| New | +$65.8K |
2017 Q3
0 quarters
|
|
|
SKIS
2177
DELISTED
Peak Resorts, Inc.
SKIS
| $65K | ﹤0.01% |
+14,870
| New | +$70.7K |
2017 Q3
0 quarters
|
|
2178
Accuray
ARAY
$19.4M
| $64K | ﹤0.01% |
+15,978
| New | +$68.6K |
2017 Q3
0 quarters
|
|
2179
The Joint Corp
JYNT
$98.9M
| $64K | ﹤0.01% |
+13,529
| New | +$55.3K |
2017 Q3
0 quarters
|
|
2180
ProQR Therapeutics
PRQR
$195M
| $64K | ﹤0.01% |
+13,150
| New | +$68.3K |
2017 Q3
0 quarters
|
|
2181
Spyre Therapeutics
SYRE
$7.44B
| $64K | ﹤0.01% |
+517
| New | +$48.5K |
2017 Q3
0 quarters
|
|
2182
DELISTED
Vaxart
VXRT
| $64K | ﹤0.01% |
+8,462
| New | +$57.6K |
2017 Q3
0 quarters
|
|
|
RTNB
2183
DELISTED
ROOT9B TECHNOLOGIES
RTNB
| $64K | ﹤0.01% |
+31,815
| New | +$129K |
2017 Q3
0 quarters
|
|
2184
China Automotive Systems
CAAS
$137M
| $63K | ﹤0.01% |
+12,196
| New | +$62.3K |
2017 Q3
0 quarters
|
|
2185
Lipocine
LPCN
$12.7M
| $63K | ﹤0.01% |
+934
| New | +$67.5K |
2017 Q3
0 quarters
|
|
2186
DELISTED
Taitron Components
TAIT
| $63K | ﹤0.01% |
+39,922
| New | +$66.2K |
2017 Q3
0 quarters
|
|
2187
TETRA Technologies
TTI
$782M
| $63K | ﹤0.01% |
+22,064
| New | +$54.1K |
2017 Q3
0 quarters
|
|
|
PZRX
2188
DELISTED
PhaseRx, Inc.
PZRX
| $63K | ﹤0.01% |
+76,739
| New | +$57.3K |
2017 Q3
0 quarters
|
|
|
MTL
2189
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $63K | ﹤0.01% |
+12,249
| New | +$62.8K |
2017 Q3
0 quarters
|
|
|
OREX
2190
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $63K | ﹤0.01% |
+29,699
| New | +$72.5K |
2017 Q3
0 quarters
|
|
2191
Matinas BioPharma
MTNB
$2.37M
| $62K | ﹤0.01% |
+63
| New | +$63.1K |
2017 Q3
0 quarters
|
|
2192
Alaunos Therapeutics
TCRT
$6.86M
| $62K | ﹤0.01% |
+67
| New | +$59.5K |
2017 Q3
0 quarters
|
|
2193
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $62K | ﹤0.01% |
+982
| New | +$69.5K |
2017 Q3
0 quarters
|
|
|
SUMR
2194
DELISTED
Summer Infant, Inc.
SUMR
| $62K | ﹤0.01% |
+3,626
| New | +$60.9K |
2017 Q3
0 quarters
|
|
|
SDLP
2195
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $62K | ﹤0.01% |
+1,667
| New | +$54.4K |
2017 Q3
0 quarters
|
|
2196
DELISTED
Carisma Therapeutics
CARM
| $61K | ﹤0.01% |
+1,927
| New | +$53.9K |
2017 Q3
0 quarters
|
|
|
CYTR
2197
DELISTED
CytRx Corp
CYTR
| $61K | ﹤0.01% |
+24,785
| New | +$83.8K |
2017 Q3
0 quarters
|
|
2198
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $60K | ﹤0.01% |
+12,642
| New | +$62.9K |
2017 Q3
0 quarters
|
|
2199
Noodles & Co
NDLS
$83.1M
| $59K | ﹤0.01% |
+1,680
| New | +$55.2K |
2017 Q3
0 quarters
|
|
2200
Origin Agritech
SEED
$9.95M
| $59K | ﹤0.01% |
+3,583
| New | +$55K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.